Target Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Charles Strother, MD, named chairman of the board. Currently a professor of radiology, neurology, and neurosurgery at University of Wisconsin Clinical Science Center, Strother recently completed his term as the first president of the American Society of Interventional and Therapeutic Neuroradiology, and has served as a Target director for four years. He replaces Richard Randall, who will remain "an active director." Randall moved to the chairman spot a year ago when Gary Bang replaced him as CEO and president